Australia’s active vaccine safety system

Publications

Totterdell J, Phillips A, Glover C, Chidwick K, Marsh J, Snelling T, Macartney K. Safety of live attenuated herpes zoster vaccine in adults 70 to 79 years: a self-controlled case series analysis using primary care data from the MedicineInsight program. Vaccine 2020;38:3968-3979. doi: 10.1016/j.vaccine.2020.03.054. [Abstract]

Phillips A, Glover C, Leeb A, Cashman P, Fathima P, Crawford C, Snelling TL, Durrheim D, Macartney K. Safety of live attenuated herpes zoster vaccine in Australian adults 70–79 years of age: an observational study using active surveillance. BMJ Open 2021;11:e043880. doi: 10.1136/bmjopen-2020-043880. [Abstract]

Glover C, Crawford N, Leeb A, Wood N, Macartney K. Active SMS-based surveillance of adverse events following immunisation with influenza and pertussis-containing vaccines in Australian pregnant women using AusVaxSafety. Vaccine 2020;38:4892-4900. doi: 10.1016/j.vaccine.2020.04.056. [Abstract]

Pillsbury AJ, Fathima P, Quinn HE, Cashman P, Blyth CC, Leeb A, Macartney K . Comparative post-market safety profile of adjuvanted and high-dose influenza vaccines in the elderly. JAMA Open 2020;3:e204079. doi: 10.1001/jamanetworkopen.2020.4079. [Full text]

Jacoby P, Glover C, Damon C, Fathima P, Pillsbury A, Durrheim D, Gold M, Leeb A, Snelling T. Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study. BMJ Open 2020;10:e031851. doi: 10.1136/bmjopen-2019-031851. [Full text]

Cashman P, Munnoch S, Clark K, Allan N, Clarke S, Macartney K, Durrheim DN. The Aboriginal gap in online active vaccine safety surveillance. Australian Indigenous Health Bulletin 2020;1. https://ro.ecu.edu.au/aihhealthbulletin/vol1/iss1/3. [Full text]

Cashman P, Moberley S, Chee K, Stephenson J, Chaverot S, Martinelli J, Gadsden T, Bateman-Steel C, Redwood L, Howard Z, Ferson MJ, Durrheim DN . Participant centred safety surveillance of health care workers receiving influenza vaccination. Vaccine 2019;37:2427-2429. doi: 10.1016/j.vaccine.2019.02.082. [Abstract]

Crawford NW, Hodgson K, Gold M, Buttery J, Wood N. Adverse events following HPV immunisation in Australia: establishment of a clinical network. Human Vaccines and Immunotherapeutics 2016;12:2662-5.. [Full text]

Pillsbury A, Glover C, Jacoby P, Quinn HE, Fathima P, Cashman P, Leeb A, Blyth CC, Gold MS, Snelling T, Macartney K. Active surveillance of 2017 seasonal influenza vaccine safety in individuals aged 6 months and older in Australia. BMJ Open 2018;8:e023263. doi: 10.1136/bmjopen-2018-023263. [Full text]

Pillsbury A, Quinn H, Cashman, Leeb A, Macartney K. Active SMS-based influenza vaccine safety surveillance in Australian children. Vaccine 2017;35:7101-7106. doi: 10.1016/j.vaccine.2017.10.091. [Full text]